Table 3.
Variables | Training cohort | Validation cohort | ||
---|---|---|---|---|
HR (95% CI) | P-value | HR (95%CI) | P-value | |
Location | 0.954 (0.863–1.054) | 0.351 | 0.943 (0.810–1.098) | 0.449 |
Sex | 1.129 (1.048–1.217) | 0.001 | 1.210 (1.077–1.360) | 0.001 |
Race | 0.999 (0.947–1.053) | 0.961 | 0.977 (0.900–1.060) | 0.569 |
Age | 1.690 (1.566–1.823) | <0.001 | 1.618 (1.439–1.819) | <0.001 |
Size | 1.112 (1.039–1.191) | 0.002 | 1.159 (1.042–1.288) | 0.006 |
Grade | 1.224 (1.165–1.286) | <0.001 | 1.244 (1.155–1.341) | <0.001 |
T stage | 1.524 (1.455–1.597) | <0.001 | 1.409 (1.314–1.511) | <0.001 |
TD status | 1.025 (1.016–1.034) | <0.001 | 1.019 (1.006–1.033) | 0.006 |
mpN stage | 1.339 (1.292–1.388) | <0.001 | 1.393 (1.318–1.473) | <0.001 |
CI, confidence interval; HR, hazard ratios; mpN, modified pN; mTNM, modified TNM; TD, tumor deposit.